Moderna Gets To Watch And Learn From Pfizer’s COVID-19 Vaccine Advisory Committee

US FDA will simultaneously review the vaccines, with Moderna’s advisory committee set a week after Pfizer’s. ACIP emergency meeting scheduled for 1 December with vote likely on distribution priority for health care personnel.

Stone/UK- November 12, 2020: Moderna Inc makes mRNA-1273 experimental COVID-19 vaccine. Vaccine jar effective in preventing 90 percent of Covid-19 Coronavirus infections
Moderna's COVID-19 vaccine candidate scheduled for advisory committee review

More from Vaccines

More from Pink Sheet